Compare Abbott Laboratories (ABT) vs iShares Global Clean Energy ETF (ICLN) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Abbott Laboratories vs iShares Global Clean Energy ETF — how do they compare? Abbott Laboratories trades at $95.42 (market cap $166.94B), while iShares Global Clean Energy ETF trades at $18.96. The key difference: Abbott Laboratories pays a 2.63% dividend while iShares Global Clean Energy ETF pays none, and iShares Global Clean Energy ETF is trading nearer its 52-week high, Abbott Laboratories nearer its low. Which is the better fit depends on your goals.
| ABT | ICLN | |
|---|---|---|
Market Cap | $166.94B | — |
Sector | Health | — |
52-Week High | $136.62 | $23.75 |
52-Week Low | $82.57 | $13.37 |
Enterprise Value | $193.69B | — |
Dividend Yield | 2.63% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Abbott Laboratories (ABT) trades at $95.63, up 0.25% on the day, with a bullish technical signal from moving averages and strong analyst support. The stock shows solid fundamentals with a P/E of 26.79 and net income margin of 13.91%, though recent earnings have been mixed. Recent news highlights regulatory approvals for new medical devices, supporting growth prospects.
The outlook remains positive with a consensus price target of $122.55, implying significant upside. Key risks include competitive pressures and macroeconomic headwinds, but strong institutional backing and consistent dividend payments provide stability for long-term investors.
ICLN, the iShares Global Clean Energy ETF, trades at $19.33, down 1.73% on the day amid a bearish technical signal, with moving averages indicating selling pressure. The fund has gained over 25% year-to-date in 2026, driven by global energy security concerns and investment in renewables, though recent U.S. permit delays and geopolitical tensions pose headwinds. A dividend of $0.06 is scheduled for June 2026.
Outlook remains mixed: strong structural trends support clean energy demand, but policy uncertainty and valuation concerns after recent gains present risks. The ETF offers diversified exposure to global renewables growth, yet investors face volatility from regulatory shifts and competition from other energy sectors.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Abbott Laboratories
Abbott manufactures and markets medical devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, molecular diagnostic platforms, and immunoassays and point-of-care diagnostic equipment. Abbott derives approximately 60% of sales outside the United States.
Read more on ABT →About iShares Global Clean Energy ETF
The index is designed to track the performance of approximately 100 clean energy-related companies. The fund generally invests at least 80% of its assets in the component securities of the target index. The index may invest up to 20% of its assets in certain futures, trading options and swap contracts, cash and cash equivalents, as well as in securities not included in the index. It is non-diversified.
Read more on ICLN →
